Venus Remedies Limited

NSE:VENUSREM.NS

343.5 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22019 Q42019 Q32019 Q22019 Q12018 Q42016 Q42013 Q42012 Q42012 Q2
Assets:
Current Assets:
Cash & Cash Equivalents 681-707.545.3-713.445212.1-649.5600.7-432.556432.556-414.48313.48-289.79288.792-60.6758.8419.424-147.1667.93-83.7620.33135.61.89327.9846.03
Short Term Investments 190.91,415690.71,426.89537.11,29957.4865.11220.549828.96108.87579.583.76121.348.550294.3279.23167.5200000
Cash and Short Term Investments 871.9707.5736713.445749.2649.5658.1432.556453.105414.48422.35289.79288.79260.6767.3919.424147.16147.1683.7620.33135.61.89327.9846.03
Net Receivables 80501,036.101,064.10565.40726.7940889.70611.3830551.03306.9050598.250930.51472.86000
Inventory 1,216.901,593.301,199.401,464.701,256.43901,335.4401,199.86701,275.021,411.24201,446.0501,427.2541,405.991,422.5561,280.266216.174
Other Current Assets 701.503720216.90265.90344.060292.410215.910254.761,448.8510325.610276.242691.751,296.71947.528158.048
Total Current Assets 3,595.3707.53,737.4713.4453,229.6649.52,954.1432.5562,780.398414.482,939.9289.792,315.95260.672,148.22,879.517147.162,517.0783.762,654.3372,606.22,721.1592,255.778380.252
Non-Current Assets:
Property, Plant & Equipment, Net 1,54401,552.501,628.201,683.401,786.2801,84001,908.23201,983.752,087.33802,542.3702,651.4945,353.262,810.3052,452.397777.148
Goodwill 0000-0.0610000000000.02000000000
Intangible Assets 852.10748.40792.4610834.70879.2850923.250967.16201,011.061,054.29901,617.2401,680.10402,262.2412,039.8940
Goodwill and Intangible Assets 852.10748.40792.40834.70879.2850923.250967.16201,011.081,054.29901,617.2401,680.10402,262.2412,039.8940
Long Term Investments 52.50-654.20-508.90-30.50-54.340-68.56039.95041.7100-50.52000000
Tax Assets 00690.70537.1057.406.8210108.870327.23708.550079.23000000
Other Non-Current Assets 224.4-707.5329.5-713.445332.4-649.5328.7-432.556399.736-414.48330.92-289.79-0-60.67330.12356.036-147.16357.24-83.76342.323331.65549.818427.403132.624
Total Non-Current Assets 2,673-707.52,666.9-713.4452,781.2-649.52,873.7-432.5563,017.782-414.483,134.48-289.793,242.581-60.673,375.213,497.673-147.164,545.56-83.764,673.9215,684.915,622.3644,919.694909.772
Total Assets 6,268.306,404.306,010.805,827.805,798.1806,074.3705,558.53305,523.416,377.1907,062.6307,328.2588,291.118,343.5167,175.4731,290.024
Liabilities & Equity:
Current Liabilities:
Account Payables 441.50560.20508.40472.30542.8640884.520713.5680725.08366.9530380.40360.027297.3312.229187.6060
Short Term Debt 26.5030.6036.1036041.661043.07044.8740185.761,483.9650905.3801,819.7091,191.591,486.591,421.3950
Tax Payables 000000000000000000000000
Deferred Revenue 47.5990497.90270.30324.50331.1940322.020206.2050474.23327.28601,297.560446.3550279.691275.6310
Other Current Liabilities 278.601010.7010.909.9011.66607.9109.804016.837.06209.65010.138491.431.40827.828310.042
Total Current Liabilities 794.201,099.40825.70842.70927.38501,257.520974.45101,401.92,185.26602,592.9902,636.2291,980.292,109.9181,912.46310.042
Non-Current Liabilities:
Long Term Debt 386.80386.80386.80386.80386.7890386.790468.310480.54720.5330970.2801,160.181,618.191,399.841,291.151238.982
Deferred Revenue Non-Current -0000475.2890469.400074.600074.930055.62057.785033.13929.1370
Deferred Tax Liabilities Non-Current 109.20118.50106.407.60002.68036.340183.36168.460150.460148.8220177.853146.80923.278
Other Non-Current Liabilities 102.6089.80-386.7890-386.8079.5420-0.01076.59500.0369.2304.690-0.001176.616.6924.6625.732
Total Non-Current Liabilities 598.60595.10581.704770466.3310464.060581.2450738.86958.22301,181.0501,366.7861,794.81,617.5241,471.759267.992
Total Liabilities 1,392.801,694.501,407.401,319.701,393.71601,721.5801,555.69602,140.763,143.48903,774.0404,003.0153,775.093,727.4423,384.219578.034
Equity:
Preferred Stock 000000000000000000000000
Common Stock 133.70133.70133.70133.70133.670133.670123.420123.42123.420123.420123.42123.42114.42105.4219.484
Retained Earnings 1,704.3140001,421.2790001,160.245000750.56700133.865000238.57301,363.0211,020.0530
Accumulated Other Comprehensive Income/Loss 4,741.84,709.84,576.14,603.3612,165.1294,508.14,374.44,404.467112.6364,352.794,219.124,002.84879.4283,382.653,259.23-2,027.1933,288.593,165.173,325.24-1,823.8374,392.60-537.9510
Other Total Stockholders Equity -1,704.314000883.2920002,997.9130002,249.422005,003.6090004,787.08703,138.6333,203.732692.506
Total Shareholders Equity 4,875.54,709.84,709.84,603.3614,603.44,508.14,508.14,404.4674,404.4644,352.794,352.794,002.844,002.8373,382.653,382.653,233.7013,288.593,288.593,325.243,325.2434,516.024,616.0743,791.254711.99
Total Equity 4,875.54,709.84,709.84,603.3614,603.44,508.14,508.14,404.4674,404.4644,352.794,352.794,002.844,002.8373,382.653,382.653,233.7013,288.593,288.593,325.243,325.2434,516.024,616.0743,791.254711.99
Total Liabilities & Shareholders Equity 6,268.34,709.86,404.34,603.3616,010.84,508.15,827.84,404.4675,798.184,352.796,074.374,002.845,558.5333,382.655,523.416,377.193,288.597,062.633,325.247,328.2588,291.118,343.5167,175.4731,290.024